| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/27/2002 | US20020082401 Nucleotide sequences coding protein for use in treating eating disorder, autoimmune and viral diseases |
| 06/27/2002 | US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 06/27/2002 | US20020082396 Reshaped human antibody to human interleukin-8 |
| 06/27/2002 | US20020082395 Immunoglobulin for use in diagnosis, treatment and prevention of bacterial infections |
| 06/27/2002 | US20020082394 Treating a cancer; obtain polypeptide coded by tumor gene, administer to human, monitor human for reduction in tumors |
| 06/27/2002 | US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto |
| 06/27/2002 | US20020082389 Method and means for site directed therapy |
| 06/27/2002 | US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders |
| 06/27/2002 | US20020082386 Monoclonal antibody for use in the detecion and prevention of bacillus anthracis infections |
| 06/27/2002 | US20020082385 Protein for use in dietetics and the treatment of diabebtes |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082217 Synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082209 Mannan binding lectin-associated serine protease-2; serine protease that acts in the MBLectin complement fixation pathway |
| 06/27/2002 | US20020082208 Mannan binding lectin-associated serine protease-2; serine protease that acts in the MBLectin complement fixation pathway |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020081723 Respiratory syncytial virus (RSV) fusion protein; treating or preventing RSV infection, as well as for diagnosis of RSV in analytes |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081713 ADP-ribosylation factor-like proteins |
| 06/27/2002 | US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081683 Polypeptide for use in the diagnosis and treatment of psoriasis, infection, asthma and immune and respiratory disorders |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081655 Splice variant of mGluR |
| 06/27/2002 | US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects |
| 06/27/2002 | US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent |
| 06/27/2002 | US20020081648 Peptide for use in human thereapeutics and diagnostics |
| 06/27/2002 | US20020081638 Method for identifying compounds altering higher-order chromatin-dependent chromosome stability |
| 06/27/2002 | US20020081635 Novel antibody compositions for preparing enriched T cell preparations |
| 06/27/2002 | US20020081631 Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins |
| 06/27/2002 | US20020081624 Detection of patients at risk for developing integrin antagonist/ agonist mediated disease states |
| 06/27/2002 | US20020081622 Nucleotide sequences which code polypeptide for use in the treatment and prevention of bacterial infection |
| 06/27/2002 | US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies |
| 06/27/2002 | US20020081580 Compounds for immunodiagnosis of prostate cancer and methods for their use |
| 06/27/2002 | US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081312 For the diagnosis and immunization of humans and animals against gastrointestinal disorders |
| 06/27/2002 | US20020081310 Apoptosis-related compounds and their use |
| 06/27/2002 | US20020081306 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists |
| 06/27/2002 | US20020081305 Altering the properties of cells or of particles with menbranes derived from cells by means of lipid-modified proteinaceous molecules |
| 06/27/2002 | US20020081303 Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders |
| 06/27/2002 | US20020081300 Administering the combination of anti-glutamic acid decarboxylase (anti-GAD) antibody and anti-insulin antibody in amount effective to treat or prevent diabetes |
| 06/27/2002 | US20020081298 An immunoglobulin or portion thereof linked to a T cell receptor agonist derived from an antigen responsible for an autoimmune disease, capable of undergoing Fc receptor medited ukptake by antigen presenting cells |
| 06/27/2002 | US20020081297 Co-administering to the mammal a recombinant virus comprising a transgene and an immune modulator which inhibits the formation of neutralizing antibodies to the recombinant virus |
| 06/27/2002 | US20020081295 Virus-like particles for the induction of autoantibodies |
| 06/27/2002 | US20020081294 Co-administering effective amounts of tissue plasminogen actiator (tPA) and ati-CD18 antibody to mammal until about three to five hours after the onset of focal ischemic stroke to increase cerebral blood flow |
| 06/27/2002 | US20020081293 Antibody, homologues, or analogues or fragments, peptide, or peptidomimetic used as serene protease inhibitor (factor D inhibitor) |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081288 A polypeptide selected from the group consisting of a SOD-4 polypeptide (superoxide dimutase) having a preferred deduced amino acid sequence and fragments, analogs and derivatives encoded by a specific polynucleotide |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2439509A1 Equine ige-allotype |
| 06/27/2002 | CA2433308A1 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432767A1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432047A1 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2431994A1 Method for the production of polyfructans |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2431485A1 Stabilization of antibodies or fragments thereof |
| 06/27/2002 | CA2431446A1 High affinity antibodies |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2430754A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/26/2002 | EP1217068A2 Oil palm (genus Elaeis) peroxiredoxin gene and uses thereof |
| 06/26/2002 | EP1217007A2 Serum paraoxonase |
| 06/26/2002 | EP1217006A2 Polypeptides and nucleic acids encoding the same |
| 06/26/2002 | EP1216994A2 Tricyclic antidepressant derivatives and immunoassay |
| 06/26/2002 | EP1216714A1 Cellular and serum protein anchors and conjugates |
| 06/26/2002 | EP1216302A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216300A1 Methods and compositions relating to sodium channel beta1a subunits |
| 06/26/2002 | EP1216258A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 06/26/2002 | EP1216056A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 06/26/2002 | EP1140168B1 Vaccination against cancer |
| 06/26/2002 | EP1007072A4 Glial cell line-derived neurotrophic factor receptors |
| 06/26/2002 | EP0574391B1 Antibodies against the urokinase receptor and their use |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355882A Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same |
| 06/26/2002 | CN1355845A PrP-like gene |
| 06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/26/2002 | CN1355843A Vascular adhesion molecules and modulation of their function |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355714A LIM Mineralization protein splice variants |
| 06/26/2002 | CN1355712A Use of antibodies against CD2O for treatment of graft versus host disease |
| 06/26/2002 | CN1355711A Method for inhibiting brain tumor growth |
| 06/26/2002 | CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes |
| 06/26/2002 | CN1355316A Polypeptide-dimethylallyl diphosphate insomerase 11.99 and polynucleotide for coding it |
| 06/26/2002 | CN1355315A Polypeptide-human dihydroorotase 14.08 and polynucleotide for coding it |
| 06/26/2002 | CN1355314A Polypeptide-human adenosine triphosphate dependent Ser protein hydrolase 11.66 and polynucleotide for coding it |